• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases.

作者信息

Lucas Kurt, Fröhlich-Nowoisky Janine, Oppitz Nicole, Ackermann Maximilian

机构信息

Multiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.

Institute of Pathology and Molecular Pathology, Helios University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany.

出版信息

Front Plant Sci. 2021 Feb 26;12:589783. doi: 10.3389/fpls.2021.589783. eCollection 2021.

DOI:10.3389/fpls.2021.589783
PMID:33719281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7952639/
Abstract
摘要

相似文献

1
Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases.肉桂和啤酒花提取物作为重症 COVID-19 病例的潜在免疫调节剂
Front Plant Sci. 2021 Feb 26;12:589783. doi: 10.3389/fpls.2021.589783. eCollection 2021.
2
Bark Extracts of Ceylon Cinnamon Possess Antilipidemic Activities and Bind Bile Acids In Vitro.锡兰肉桂的树皮提取物具有抗血脂活性并在体外结合胆汁酸。
Evid Based Complement Alternat Med. 2017;2017:7347219. doi: 10.1155/2017/7347219. Epub 2017 Jul 20.
3
Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion.肉桂具有物种特异性的抗糖尿病特性：对酶活性抑制和淀粉消化的影响。
Plant Foods Hum Nutr. 2019 Dec;74(4):544-552. doi: 10.1007/s11130-019-00760-8.
4
Characteristics of compounds in hops using cyclic voltammetry, UV-VIS, FTIR and GC-MS analysis.使用循环伏安法、紫外可见光谱法、傅里叶变换红外光谱法和气相色谱-质谱联用分析法对啤酒花中的化合物特性进行分析。
Food Chem. 2014 Aug 1;156:353-61. doi: 10.1016/j.foodchem.2014.02.005. Epub 2014 Feb 12.
5
Mutagenicity of extracts from Ceylon cinnamon in the rec assay.锡兰肉桂提取物在回复突变试验中的致突变性。
Food Chem Toxicol. 1984 Feb;22(2):109-12. doi: 10.1016/0278-6915(84)90089-9.
6
Analysis of pesticide residues in hops and their extraction by liquid CO2 during the production of hop extracts.啤酒花中农药残留分析及其在啤酒花提取物生产过程中通过液态二氧化碳进行提取的研究。
Food Addit Contam. 1994 Sep-Oct;11(5):615-9. doi: 10.1080/02652039409374261.
7
Composition and In Vitro Effects of Cultivars of L. Hops on Cholinesterase Activity and Microbial Growth.啤酒花品种对乙酰胆碱酯酶活性和微生物生长的组成和体外影响。
Nutrients. 2019 Jun 19;11(6):1377. doi: 10.3390/nu11061377.
8
New identification of proanthocyanidins in cinnamon (Cinnamomum zeylanicum L.) using MALDI-TOF/TOF mass spectrometry.采用 MALDI-TOF/TOF 质谱法对肉桂（Cinnamomum zeylanicum L.）中原花青素的新鉴定。
Anal Bioanal Chem. 2012 Jan;402(3):1327-36. doi: 10.1007/s00216-011-5557-3. Epub 2011 Nov 20.
9
Interaction of alcoholic extracts of hops with cocaine and paracetamol in mice.啤酒花酒精提取物与可卡因及对乙酰氨基酚在小鼠体内的相互作用。
Eur J Drug Metab Pharmacokinet. 2007 Jan-Mar;32(1):39-44. doi: 10.1007/BF03190988.
10
Use of GC-olfactometry to identify the hop aromatic compounds in beer.使用气相色谱 - 嗅觉测定法鉴定啤酒中的啤酒花芳香化合物。
J Agric Food Chem. 2001 Aug;49(8):3867-74. doi: 10.1021/jf0101509.

引用本文的文献

1
Strategies for the Management of Spike Protein-Related Pathology.刺突蛋白相关病理学的管理策略。
Microorganisms. 2023 May 17;11(5):1308. doi: 10.3390/microorganisms11051308.
2
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19.植物作为生产治疗性蛋白质和抗病毒化合物以对抗新冠病毒的生物工厂。
Life (Basel). 2023 Feb 23;13(3):617. doi: 10.3390/life13030617.
3
An Updated Review of the Genus : A Valuable Source of Bioactive Compounds for Health and Disease Prevention.该属的最新综述：健康与疾病预防生物活性化合物的宝贵来源。
Plants (Basel). 2022 Dec 8;11(24):3434. doi: 10.3390/plants11243434.
4
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?2019冠状病毒病抗病毒药物治疗概述：我们目前的进展如何？
Biomedicines. 2022 Nov 4;10(11):2815. doi: 10.3390/biomedicines10112815.
5
Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review.COVID-19 感染后缓解神经、心血管和呼吸道症状的草药：文献综述。
Cells. 2022 Jun 11;11(12):1897. doi: 10.3390/cells11121897.
6
Natural therapeutics against SARS CoV2: the potentiality and challenges.针对新型冠状病毒2的天然疗法：潜力与挑战。
Vegetos. 2023;36(2):322-331. doi: 10.1007/s42535-022-00401-7. Epub 2022 Jun 15.
7
Plant-Derived Natural Products as Lead Agents against Common Respiratory Diseases.植物源天然产物作为治疗常见呼吸道疾病的先导药物。
Molecules. 2022 May 10;27(10):3054. doi: 10.3390/molecules27103054.
8
Synthesis of Human Phase I and Phase II Metabolites of Hop () Prenylated Flavonoids.蛇麻素（）异戊烯基黄酮类化合物的人源Ⅰ相和Ⅱ相代谢产物的合成
Metabolites. 2022 Apr 12;12(4):345. doi: 10.3390/metabo12040345.
9
Neutralizing the free radicals could alleviate the disease severity following an infection by positive strand RNA viruses.中和自由基可以减轻正链 RNA 病毒感染后的疾病严重程度。
Cell Stress Chaperones. 2022 May;27(3):189-195. doi: 10.1007/s12192-022-01269-x. Epub 2022 Apr 3.
10
Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.新型冠状病毒肺炎的风险：重新审视植物治疗干预的益处
Molecules. 2021 Nov 10;26(22):6783. doi: 10.3390/molecules26226783.

本文引用的文献

1
Efficacy of cinnamon patch treatment for alleviating symptoms of overactive bladder: A double-blind, randomized, placebo-controlled trial.肉桂贴片治疗过度活跃膀胱症状的疗效：一项双盲、随机、安慰剂对照试验。
Phytomedicine. 2021 Jan;80:153380. doi: 10.1016/j.phymed.2020.153380. Epub 2020 Oct 12.
2
Risks and features of secondary infections in severe and critical ill COVID-19 patients.COVID-19 重症和危重症患者继发感染的风险和特征。
Emerg Microbes Infect. 2020 Dec;9(1):1958-1964. doi: 10.1080/22221751.2020.1812437.
3
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Effect of cinnamon on migraine attacks and inflammatory markers: A randomized double-blind placebo-controlled trial.肉桂对偏头痛发作和炎症标志物的影响：一项随机双盲安慰剂对照试验。
Phytother Res. 2020 Nov;34(11):2945-2952. doi: 10.1002/ptr.6721. Epub 2020 Jul 7.
5
Hepatic consequences of COVID-19 infection. Lapping or biting?COVID-19 感染的肝脏后果。舔舐还是咬伤？
Eur J Intern Med. 2020 Jul;77:18-24. doi: 10.1016/j.ejim.2020.05.035. Epub 2020 Jun 1.
6
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.COVID-19 感染对神经系统疾病发展的即时和长期影响。
Alzheimers Res Ther. 2020 Jun 4;12(1):69. doi: 10.1186/s13195-020-00640-3.
7
COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia.新型冠状病毒肺炎：对呼吸机相关性细菌性肺炎的警示
Infect Dis Ther. 2020 Sep;9(3):417-420. doi: 10.1007/s40121-020-00306-5. Epub 2020 May 30.
8
Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review.冠状病毒发病机制、合并症和多器官损伤 - 综述。
Life Sci. 2020 Aug 15;255:117839. doi: 10.1016/j.lfs.2020.117839. Epub 2020 May 22.
9
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
10
Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19.识别和管理 COVID-19 患者的呼吸道合并感染和继发性细菌性肺炎。
Cleve Clin J Med. 2020 Nov 2;87(11):659-663. doi: 10.3949/ccjm.87a.ccc015.